BioWorld

Oct. 12, 2004

DeCode Gets $24M To Study Genetics Of Infectious Disease

Working to better understand infectious diseases, the University of New Mexico is joining with DeCode Genetics Inc. and the National Center for Genome Resources in a five-year research agreement. (BioWorld Today) Read More

$3B Stem Cell Measure Likely To Pass, But Funds Problematic

From Embryonic To Adult: Recent Stem Cell Research

Rexahn's Hopper Includes More Than Phase I Cancer Compound

Clarification

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for July 7, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for July 7, 2025.

House passes H.R. 1, restoring R&D tax cuts

BioWorld MedTech

The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...

Illustration of the β2-adrenergic receptor

Exercise-mimicking compound offers alternative to GLP-1 therapies

BioWorld

An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...

3D rendering of a molecular glue mediating the interaction between two proteins

With surface mimicry, molecular glues shed hairpin need

BioWorld Science

Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...